Cuidado farmacêutico em pessoas com transtorno depressivo: análise da efetividade no tratamento

Abstract

In Brazil, drug therapy is considered the first therapeutic choice for depression; however, it may be associated with problems such as adverse reactions, drug interactions, and lack of concussion. The pharmacist may be able to improve treatment outcomes by providing services such as patient education in health, monitoring treatment regularly and improving support. Therefore, the aim of this study was to analyze the impact of Pharmaceutical Care on the effectiveness of treatment, of users of the Psychiatric outpatient clinic of the Dr. Alberto Lima Hospital of Clinics, diagnosed with depressive disorder. A longitudinal and prospective, analytical-descriptive, and intervention study was carried out. Thirty-five people were followed for 90 days, submitted to pharmaceutical care and the Beck Depression Inventory, before and after care. The consultations followed the Dáder methodology, four pharmaceutical consultations, one initial, and the other, within 30, 60 and 90 days, respectively, all by telephone. The results obtained were, regarding the socio-demographic profile of the population, females (74.3%), aged between 18 and 30 years, single and students, prevailed. As for the drug profile, Selective Serotonin Reuptake Inhibitors were the most prescribed. Among the Negative Results associated with the use of identified drugs, the health problem not treated by not using the medication they need was the most common, and non-medication was the most frequent cause. Ninety-one interventions were performed, 48 of which were accepted and with solved problems, ending the study with 15 regular associations. After the statistical analysis of the scores obtained, it was observed that there was an improvement in the intensity of depressive symptoms, statistically proven with the T-Test for paired samples, with statistically significant difference in both moments, and in the means and dispersion, between the scores of the first and second moments, p ≤ 0.001 was obtained. And at the percentage level, the Chi square test showed a statistically significant difference, with p ≤ 0.025.